Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2820316rdf:typepubmed:Citationlld:pubmed
pubmed-article:2820316lifeskim:mentionsumls-concept:C0085133lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C0699040lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C0221912lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C0054950lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C0332448lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C1456796lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C1705984lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C1518071lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:2820316lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:2820316pubmed:issue5lld:pubmed
pubmed-article:2820316pubmed:dateCreated1987-10-22lld:pubmed
pubmed-article:2820316pubmed:abstractTextSkin biopsy specimens from normal skin and from 115 patients with benign dermatoses, pre- or pseudo-malignant disorders or malignant cutaneous lymphomas have been examined immunohistologically for expression of the Reed-Sternberg cell associated antigen CD30 detected by monoclonal antibodies Ki-1 and Ber-H2. The antibodies stained the atypical cells in lymphomatoid papulosis, a proportion of the neoplastic cells in some cases of mycosis fungoides and most of the neoplastic cells in six large cell anaplastic/pleomorphic non-Hodgkin's lymphomas. The lymphoid cells in all other specimens were Ki-1- and Ber-H2-negative. In all cases, expression of the Ki-1/Ber-H2 antigen was accompanied by expression of activation and proliferation associated markers (i.e., HLA-DR, IL-2 receptor, transferrin receptor and the Ki-67 nuclear antigen). These data indicate the value of antibodies Ki-1 and Ber-H2 in distinguishing between lymphomatoid papulosis and other types of pre- or pseudo-malignant disorders and support the view that lymphomatoid papulosis, Hodgkin's disease and some types of non-Hodgkin's lymphoma constitute a spectrum of related disorders, originated from activated lymphoid cells.lld:pubmed
pubmed-article:2820316pubmed:languageenglld:pubmed
pubmed-article:2820316pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2820316pubmed:citationSubsetIMlld:pubmed
pubmed-article:2820316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2820316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2820316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2820316pubmed:statusMEDLINElld:pubmed
pubmed-article:2820316pubmed:issn0340-3696lld:pubmed
pubmed-article:2820316pubmed:authorpubmed-author:MasonD YDYlld:pubmed
pubmed-article:2820316pubmed:authorpubmed-author:SteinHHlld:pubmed
pubmed-article:2820316pubmed:authorpubmed-author:GatterK CKClld:pubmed
pubmed-article:2820316pubmed:authorpubmed-author:BossLLlld:pubmed
pubmed-article:2820316pubmed:authorpubmed-author:GerdesJJlld:pubmed
pubmed-article:2820316pubmed:authorpubmed-author:SchwartingRRlld:pubmed
pubmed-article:2820316pubmed:authorpubmed-author:RalfkiaerEElld:pubmed
pubmed-article:2820316pubmed:issnTypePrintlld:pubmed
pubmed-article:2820316pubmed:volume279lld:pubmed
pubmed-article:2820316pubmed:ownerNLMlld:pubmed
pubmed-article:2820316pubmed:authorsCompleteYlld:pubmed
pubmed-article:2820316pubmed:pagination285-92lld:pubmed
pubmed-article:2820316pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:meshHeadingpubmed-meshheading:2820316-...lld:pubmed
pubmed-article:2820316pubmed:year1987lld:pubmed
pubmed-article:2820316pubmed:articleTitleExpression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates.lld:pubmed
pubmed-article:2820316pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2820316pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2820316lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2820316lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2820316lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2820316lld:pubmed